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Abstract
Mechanical ventilation (MV) is a life-saving intervention in patients in respiratory failure.
Unfortunately, prolonged MV results in the rapid development of diaphragm atrophy and
weakness. MV-induced diaphragmatic weakness is significant because inspiratory muscle
dysfunction is a risk factor for problematic weaning fromMV. Therefore, developing a clinical
intervention to prevent MV-induced diaphragm atrophy is important. In this regard, MV-
induced diaphragmatic atrophy occurs due to both increased proteolysis and decreased pro-
tein synthesis. While efforts to impedeMV-induced increased proteolysis in the diaphragm
are well-documented, only one study has investigated methods of preserving diaphragmatic
protein synthesis during prolonged MV. Therefore, we evaluated the efficacy of two thera-
peutic interventions that, conceptually, have the potential to sustain protein synthesis in the
rat diaphragm during prolonged MV. Specifically, these experiments were designed to: 1)
determine if partial-support MV will protect against the decrease in diaphragmatic protein
synthesis that occurs during prolonged full-support MV; and 2) establish if treatment with a
mitochondrial-targeted antioxidant will maintain diaphragm protein synthesis during full-sup-
port MV. Compared to spontaneously breathing animals, full support MV resulted in a signifi-
cant decline in diaphragmatic protein synthesis during 12 hours of MV. In contrast,
diaphragm protein synthesis rates were maintained during partial support MV at levels com-
parable to spontaneous breathing animals. Further, treatment of animals with a mitochon-
drial-targeted antioxidant prevented oxidative stress during full support MV and maintained
diaphragm protein synthesis at the level of spontaneous breathing animals. We conclude
that treatment with mitochondrial-targeted antioxidants or the use of partial-support MV are
potential strategies to preserve diaphragm protein synthesis during prolongedMV.
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Introduction
Mechanical ventilation (MV) is used to provide adequate pulmonary ventilation in patients
that require ventilatory support arising from respiratory failure, drug overdose, spinal cord
injury, and surgery. Two different modes of MV are commonly used clinically: 1) full-support
MV; and 2) partial-support MV. During full-support MV the ventilator performs all of the
work of breathing and the patient’s inspiratory muscles are inactive. In contrast, during partial
support MV the ventilator provides a portion of the work of breathing and the patient’s inspi-
ratory muscles provide the remainder. Unfortunately, full-support MV results in the rapid
development of diaphragm weakness due to both myofiber atrophy and contractile dysfunc-
tion, a condition commonly referred to as ventilator-induced diaphragm dysfunction (VIDD)
[1]. The development of VIDD is important because diaphragmatic weakness is predicted to
contribute to problems in weaning patients fromMV, and therefore developing clinical inter-
ventions to prevent MV-induced diaphragm weakness is essential [2–4]. Additionally, one of
the most severe consequences of ventilating critically ill patients is impaired respiratory muscle
function [5–7]. In fact, evidence in ventilated critically ill patients demonstrates that severe dia-
phragm weakness is associated with poor patient outcomes, further demonstrating the need for
clinical interventions [4].
Similar to other forms of disuse muscle atrophy, VIDD occurs because of an imbalance
between the rates of protein degradation and protein synthesis [8–13]. Previously, our group
and others have demonstrated that as few as 12 hours of full-support mechanical ventilation
results in increased proteolysis in the diaphragm [10, 14–21]. Further, prolonged full-support
MV promotes a rapid decrease in protein synthesis in the diaphragm beginning as early as 6
hours after the initiation of MV [8, 22]. Therefore, the ideal strategy to prevent MV-induced
diaphragmatic atrophy would be to prevent both the MV-induced decrease in protein synthesis
and increase in proteolysis in the diaphragm.
Numerous studies have explored therapeutic strategies to impede MV-induced protease acti-
vation in the diaphragm and several pharmacological approaches can delay the rate of MV-
induced diaphragm proteolysis [19, 23–25]. For example, we previously demonstrated that full
support MV results in increased mitochondrial ROS production in the diaphragm and treatment
with the mitochondrial-targeted antioxidant SS-31 can prevent both the MV-induced increase
in mitochondrial ROS emission and the increase in proteolysis in the diaphragm [19, 21]. Fur-
ther, this prevention of mitochondrial generated ROS prevented diaphragmmuscle atrophy and
contractile dysfunction. However, to date, no studies have investigated the effects of mitochon-
drial antioxidants on maintaining diaphragmmuscle protein synthesis during full support MV.
Also, in addition to pharmacological approaches, another therapeutic approach that has the
potential to delay the rate of MV-induced proteolysis is the use of partial-support MV which
permits diaphragm contractile activity, albeit at lower activation levels than required for spon-
taneous breathing. Previously, we reported that compared to full support MV, partial-support
MV delays the activation of proteolytic systems in the diaphragm as well as diaphragm atrophy
and contractile dysfunction [26]. Further, a previous report investigating the effects of partial-
support MV on maintaining diaphragm protein synthesis showed positive results [22]. Unfor-
tunately, currently during prolonged MV there is no established therapeutic intervention to
maintain protein synthesis in the diaphragm. Thus, developing therapeutic strategies, includ-
ing mitochondrial antioxidant treatment or partial-support MV to prevent the MV-induced
decrease in protein synthesis is important and forms the rationale for the current experiments.
Using an animal (rat) model of MV that exhibits diaphragm dysfunction similar to that
observed in the human diaphragm during full-support MV, these experiments investigated two
independent strategies that have the potential to sustain anabolic signaling and maintain protein
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synthesis in the diaphragm during prolonged MV. First, we replaced full-support MV with par-
tial support MV to test the hypothesis that even low levels of diaphragm contractile activity can
maintain diaphragm protein synthesis during prolonged MV.We also tested a second hypothe-
sis that treatment of animals with a mitochondrial-targeted antioxidant will prevent MV-
induced diaphragmatic oxidative stress and protect the diaphragm against MV-induced
decreases in protein synthesis. This hypothesis was formulated from the knowledge that oxida-
tive stress can blunt anabolic signaling and decreases protein synthesis in cells [27–29].
Methods
Experimental Animals
Adult female Sprague-Dawley rats were used in these experiments. Animals were maintained
on a 12:12 hour light-dark cycle and provided food and water ad libitum throughout the exper-
imental period. The Institutional Animal Care and Use Committee of the University of Florida
approved these experiments.
Experimental Design
These experiments determined the effectiveness of two therapeutic interventions to protect
against full-support MV-induced decreases in diaphragm muscle protein synthesis. Specifi-
cally, these experiments were designed to achieve two objectives: 1) To determine if partial-
support MV (when a patient’s inspiratory muscles provide a portion of the work of breathing)
can maintain diaphragm protein synthesis at levels comparable to spontaneous breathing; and
2) To establish if treatment of animals with a mitochondrial-targeted antioxidant can prevent
MV-induced oxidative stress and protect against the decreased diaphragmatic protein synthesis
that occurs during prolonged full-support MV. To achieve these objectives adult female Spra-
gue-Dawley rats were randomly assigned to one of the following groups: 1) Anesthetized and
spontaneously breathing (SB); 2) Full-support MV using controlled mechanical ventilation
(CMV); 3) Partial support MV using a pressure support mode (PSV) of MV; and 4) Exposed to
CMV and treated with the mitochondrial-targeted antioxidant SS-31 to prevent MV-induced
oxidative stress (CMVSS). All groups were exposed to a 12-hour treatment period (N = 8/
group). At the completion of the experimental periods the animals were immediately sacrificed
and the costal diaphragm quickly removed and stored at -80°C for subsequent analyses.
Spontaneous Breathing
The SB animals breathed spontaneously during the duration of the experiment and served as
time-matched controls for the MV groups. The SB animals were not mechanically ventilated, but
received the same anesthetic dose, surgical intervention, and technical care as the MV animals.
Mechanical ventilation
All animals assigned to full-support MV (CMV) and partial support ventilation (PSV) were
acutely anesthetized with sodium pentobarbital (60 mg/kg (intraperitoneal) (IP)). Specific
experimental details of our animal model of CMV has been described in detail previously (25).
Partial support mechanical ventilation
Animals on PSV were acutely anesthetized with sodium pentobarbital (60 mg/kg IP). After
reaching a surgical plane of anesthesia, the animals were tracheostomized and ventilated using
partial-support ventilation as previously described [26].
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Mitochondrial-targeted antioxidant administration
Animals assigned to the CMVSS group were anesthetized and exposed to CMV using the afore-
mentioned procedures. We selected the mitochondria-targeted antioxidant designated as “SS-
31” for use in these experiments. This molecule belongs to a family of small, water-soluble pep-
tides that contain an alternating aromatic-cationic motif (D-Arg-2’6’dimethylTyr-Lys-Phe-
NH2) that has been shown to selectively target and concentrate ~5000-fold on the inner mito-
chondrial membrane [30, 31]. Furthermore, numerous studies have shown that SS-31 can
selectively scavenge mitochondrial ROS and protect mitochondrial function [32]. The mito-
chondrial-targeted antioxidant SS-31 was administered as previously described [19]. Briefly,
SS-31 was dissolved in saline and delivered in a bolus (loading) dose (3 mg/kg, subcutaneous
injection) and a constant intravenous infusion (0.05 mg/kg/hr) of SS-31 was maintained
throughout MV.
Assessment of the work of breathing during partial-support MV
To determine the level of breathing support provided by the ventilator during PSV, we mea-
sured the inspiratory muscle time-tension index in both spontaneous breathing rats and ani-
mals undergoing PSV as previously described [26]. Briefly, we measured the inspiratory
pressure generated and the temporal components of the breathing cycle in four rats that were
switched back and forth between spontaneous breathing and PSV.
This was performed by obtaining pressure measurements while the animal was connected
to ventilator and receiving PSV and measuring peak negative inspiratory pressure prior to ven-
tilator triggering. After these measures were obtained, the animal was disconnected from the
ventilator and peak negative inspiratory pressures were measured during spontaneous breath-
ing. This was achieved using a technique described by Mortola and colleagues [33] in which
the animal was connected to a non-rebreathing valve (Hans Rudolf model #2300 valve, Shaw-
nee, KS). Specifically, the upper airway pressures generated during inspiration were measured
using a rapid response and sensitive pressure transducer (AutoTran, Eden Prairie, MN). Using
mean values for 30–50 breathing cycles the inspiratory muscle time-tension index was com-
puted as (Ti/Ttot)x(Pneg/Pimax) where Ti is the inspiratory time, Ttot is the total duration of
the respiratory cycle, Pneg is inspiratory pressure and Pmax is the estimated maximal inspira-
tory pressure generated by the respiratory system in rats (i.e., −80 cmH2O) [34].
In Vivomeasurement of protein synthesis
For the determination of rate of mixed muscle protein synthesis, [ring-2H5]- phenylalanine
(priming dose, 3.945 μmol  kg−1 followed by a continuous infusion rate, 0.1013 μmol  kg−1
min−1, Cambridge Isotope Laboratories, Andover, MA) was administered intravenously dur-
ing the last 6 hours of each experimental period using previously described techniques from
our group [8]. For the isolation of protein-bound amino acids, 20 mg of muscle was homoge-
nized and mixed muscle proteins precipitated by 10% trichloroacetic acid (TCA) and purified
by centrifugation at 1000 x g. Precipitation and centrifugation was repeated for a total of 3
times. Samples were washed with water followed by the addition of ethanol which was evapo-
rated until dry at 100°C. The resulting protein bound amino acids were hydrolyzed in 400 μL
of 6 N HCL and heated at 100°C for 24 hours. Arterial samples at 0.5, 2, 4, 6 h throughout the
protocol were measured to verify plateau enrichment of the precursor pool. Plasma samples
were de-proteinized with 1:1 ratio of 15% sulfosalicylic acid, and amino acids separated by cen-
trifugation at 10,000 x g. Before derivatization, all samples were washed over a cation exchange
column (Dowex AG 50W-8X, 100–200 mesh, H+ form, Sigma-Aldrich, St. Louis, MO) eluted
from the column with 2 N ammonium hydroxide, collected and dried under a vacuum (Savant
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SpeedVac, ThermoFisher Scientific, Waltham, MA). Once dried, samples were derivatized at
70°C for 4 hours with 100 μL of acetonitrile and N-methyl-N-(t-butyldimethylsilyl) trifluoroa-
cetamide (MTBSTFA, Pierce Chemical, Rockford, IL) at a 1:1 ratio.
The tracer:tracee ratio for [ring-2H5]-phenylalanine:phenylalanine was determined by gas
chromatography/mass spectrometry (model GC-7820 coupled with MS-5975, Agilent Tech-
nologies, Wilmington, DE) under electron impact and selective ion recording [35]. For phenyl-
alanine, m/z 234 (m + 0), 237 (m +3), and 239 (m + 5) were monitored, with m+0 representing
the lowest molecular weight of the ion and m+5 representing [ring-2H5]-phenylalanine. Plasma
enrichment is determined by the ratio of m+5/m+0 and protein bound enrichment will be
determined by m+5/m+3 in order to increase sensitivity due to relatively low abundance of m
+5 [36]. The fractional rate of protein synthesis (FSR) per hour was calculated as the incorpo-
ration of stable isotope into the protein bound pool of muscle divided by the plasma concentra-
tion at the final time point as a function of time: FSR = Et  (Ep x t)  100 where t is the time, in
hours, the tissue was subjected to tracer, and Et and Ep are the enrichments of [ring-
2H5]-phe-
nylalanine in hydrolyzed tissue protein an in plasma amino acids, respectively.
Western Blot Analysis
Protein content was compared across groups via Western Blot analysis using previously
described methods [12, 16]. 4-hydroxynonenal (4-HNE) conjugated proteins were measured
as an index of oxidative damage (Abcam, Cambridge, MA; product #46546). To measure mark-
ers of protein synthesis signaling, membranes were incubated with antibodies against phos-
phorylated Akt (Ser 473), phosphorylated proline rich Akt substrate of 40kD (PRAS40) (Thr
246), phosphorylated mammalian target of rapamycin (mTOR) (Ser 2448), and phosphory-
lated 4E-binding protein 1 (4E-BP1) (Thr 37/46), all purchased from Cell Signaling Technol-
ogy (Danvers, MA). Subsequently, membranes were stripped, blocked, and incubated with
antibodies against total Akt, GSK3β, PRAS40, mTOR, ribosomal protein s6, and 4E-BP1 all
purchased from Cell Signaling Technologies (Danvers, MA). For all western blots where both
phosphorylated protein and total protein were measured, the data were analyzed as a ratio of
the phosphorylated to total protein ratio by dividing the density of phosphorylated protein by
the density of total protein. All western blots were normalized to α-tubulin as a loading control.
Product numbers for specific antibodies from Cell Signaling Technologies are as follows: Akt
(#2920), pAkt (#4058), PRAS40 (#2691), PRAS40 (#2997), p-mTOR (#5536), mTOR (#2983),
4E-BP1 (#9452), and p-4E-BP1 (#9459).
Statistical Analysis
Group sample size was determined via use of a power analysis of preliminary data from our
laboratory. Comparisons between groups were made by a one-way ANOVA, and when appro-
priate a Student-Newman-Keuls test was performed post hoc. Note that due to the large num-
ber of groups in the experimental design, western blot data were analyzed only within the same
time period. Significance was established at p< 0.05.
Results
Diaphragm activation during PSV
Prior to beginning these experiments, we established the level of ventilatory support provided
to the experimental animals during PSV. Specifically, to determine the level of diaphragm
work during these experiments, we measured the TTI in animals ventilated using PSV and
spontaneously breathing animals (Table 1). Note that TTI is often used to estimate both the
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mechanical load and energy use of the diaphragm during breathing [37]. By comparing the
TTI between SB and PSV animals, we estimate that our trigger setting on the ventilator reduced
the total work of spontaneous breathing by ~67%. That is, during PSV, the animals’ inspiratory
muscles performed ~33% of the work of breathing.
Comparison of Respiratory Work
Systemic and biological response to MV
No significant differences existed in animal body weight between experimental groups before
or after the experimental period. Heart rate (HR), systolic blood pressure (SBP), and body tem-
perature (T) remained relatively constant during all MV protocols (HR range = 350–420 beats/
min; SBP = 70–130 mmHg; T = 36–37°C). The arterial partial pressures of O2 (PaO2) and CO2
(PaCO2) were also reasonably constant during MV in all experimental groups. Specifically,
PaO2 ranged from 65–100 mmHg whereas PaCO2 ranged from 32–42 mmHg. Importantly, at
the completion of all MV protocols, there were no visual abnormalities of the lungs or perito-
neal cavity, no sign of significant lung damage, and no evidence of infection.
Mechanical ventilation-Induced oxidative stress
Lipid peroxidation occurs in cells in response to increased oxidant production and among the
end products are several biologically active aldehydes (e.g., 4-HNE) that can be used as bio-
markers of oxidative stress [38]. Our results indicate that 12 hours of CMV significantly
increased diaphragmatic levels of 4-HNE (Fig 1). This is notable because oxidant stress is a
required upstream trigger for the development of VIDD [9, 19, 24, 39–42]. Importantly, the
current findings reveal that the use of PSV is sufficient to prevent ventilator-induced increases
in 4-HNE in the diaphragm (p<0.05). Although 4-HNE is not a specific biomarker of mito-
chondrial generated ROS, the treatment of animals with the mitochondrial targeted antioxi-
dant SS-31 is sufficient to prevent ventilator-induced increases in 4-HNE in the diaphragm
(p<0.05) (Fig 1). This suggests that ventilator-induced increases in diaphragm lipid peroxida-
tion occurred due to increased mitochondrial ROS production.
Rates of diaphragmmuscle protein synthesis
In vivo protein synthesis (i.e., fractional rate of mixed protein synthesis) in the diaphragm was
measured by the incorporation of a labeled amino acid ([ring-2H5]-phenylalanine) into newly
synthesized proteins. In agreement with previous work [8], our findings reveal that compared
to anesthetized and time-matched spontaneously breathing animals, 12 hours of CMV results
Table 1. Comparison of respiratory work between spontaneously breathing animals (SB) and animals
ventilated with PSV.
Parameter SB group PSV group
Ti (seconds) 0.175 0.050 *
Ttot (seconds) 0.877 1.048 *
Pneg (cm H2O) -0.044 -0.058
TTI 0.0001082 0.00003599 *
Key: Ti = inspiratory time; Ttot = time of a breathing cycle; Pneg = inspiratory pressure; TTI—time tension
index.
* indicates p<0.05.
doi:10.1371/journal.pone.0137693.t001
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in a significant decrease in the rate of mixed muscle protein synthesis. Importantly, compared
to CMV, PSV protected the diaphragm against CMV-induced decreases in diaphragm protein
synthesis during ventilator support (Fig 2). Further, prevention of oxidative stress was success-
ful in protecting against CMV-induced decreases in diaphragm protein synthesis during pro-
longed CMV (Fig 2).
AKT/mTORC1 signaling in the diaphragm during prolonged MV
To gain insight into the effect of our experimental treatments on the signaling pathways that
regulate diaphragm protein synthesis we measured key components of the AKT/mTORC1 sig-
naling pathway. Specifically, active (phosphorylated) AKT (p-AKT) is a protein kinase that
plays an important role in regulating muscle protein synthesis via regulation of mTORC1 and
ultimately translation. Our results reveal that 12 hours of CMV significantly lowered the ratio
of p-AKT to AKT in the diaphragm compared to SB, PSV, and CMVSS animals (p<0.05) (Fig
3). In contrast, no differences existed in the diaphragmatic p-AKT to AKT ratio between the
SB, PSV, and CMVSS groups; this indicates that both interventions (i.e., PSV and mitochon-
drial antioxidant treatment) were successful in maintaining higher AKT phosphorylation in
the diaphragm compared to the CMV animals. This finding is significant because active (i.e.,
phosphorylated) AKT has the potential to increase the rates of protein synthesis via activation
Fig 1. The levels of 4 hydroxynonenal (4-HNE) conjugated proteins in the diaphragm at 12 hours were measured via western blotting as an index
of lipid peroxidation. A representative blot for 4-HNE protein conjugates is shown below the graph. The multiple bands represent different proteins modified
by HNE-adducts, and give a general index of oxidative damage. Values are means ± SE and normalized to percent control. Symbols: * significantly different
(p<0.05) from all other groups.
doi:10.1371/journal.pone.0137693.g001
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of mTORC1. Indeed, activated mTORC1 plays a central role in promoting protein synthesis
through the phosphorylation and activation of p70S6K and its target, rpS6, and phosphoryla-
tion of 4E-BP1 which removes the repression of eIF-4E on protein translation. Together, this
cascade of events results in increased translation and thus increased rates of protein synthesis.
In addition to direct phosphorylation of mTORC1, active AKT can also regulate mTORC1
activity through the phosphorylation of PRAS40 which facilitates mTORC1 activation by
decreasing the binding affinity of PRAS40 to the mTORC1 complex [43]. In this regard, pro-
longed CMV decreased the ratio of both p-PRAS40/PRAS40 and p-mTOR/mTOR in the dia-
phragm (Figs 4 and 5). Nonetheless, it is unclear if these parallel changes in the
phosphorylation status of PRAS40 and mTOR represent a cause and effect relationship.
The protein 4E-BP1 is a substrate of mTORC1 and when activated by mTORC1, 4E-BP1
can promote the initiation of translation. Therefore, we measured the p-4E-BP1/4E-BP1 ratio
in the diaphragm of all experimental groups. Our results reveal that compared to spontaneous
breathing animals, prolonged CMV resulted in a significant reduction in the ratio of p-
4E-BP1/4E-BP1 in the diaphragm (Fig 6). In contrast, the ratio of p-4E-BP1/4E-BP1 in the dia-
phragm did not differ between the spontaneous breathing animals and the PSV and CMVSS
groups. Therefore, it is feasible that the higher ratio of p-4E-BP1/4E-BP1 contributed to the
higher levels of protein synthesis in the diaphragms of the PSV and CMVSS animals.
Fig 2. Mixed protein fractional synthesis rate (FSR) in the diaphragm following 12 hours of spontaneous breathing or mechanical ventilation.
Values are expressed as percent change per hour (mean ± SE). Note that these 12 hour values represent an average FSR during 6–12 hours of the
experiments. Symbols: * significantly different (p<0.05) from all other groups.
doi:10.1371/journal.pone.0137693.g002
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Fig 3. Ratio of p-AKT to total AKT protein in the diaphragm following 12 hours spontaneous breathing or mechanical ventilation. Representative
western blots are shown below the graph. Values are expressed as (mean ± SE) change from percent control. Symbols: δ significantly different (p<0.05) from
SB and CMVSS.
doi:10.1371/journal.pone.0137693.g003
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Discussion
Overview of Principal Findings
Currently, there are no established therapeutic interventions to maintain protein synthesis in
the diaphragm during prolonged ventilator support. The current experiments addressed this
issue and provide novel findings regarding two divergent and beneficial approaches to
Fig 4. Ratio of p-PRAS40 to total PRAS40 protein after 12 hours spontaneous breathing or mechanical ventilation. Representative western blots are
shown below the graph. Values are expressed as mean ± SE change from percent control. Symbols: * significantly different (p<0.05) from all other groups.
doi:10.1371/journal.pone.0137693.g004
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maintain diaphragmatic protein synthesis during prolonged ventilator support. Specifically,
our results reveal that compared to CMV, PSV protects against ventilator-induced decreases in
the rate of diaphragm protein synthesis during the first 12 hours of ventilator support. Further,
our data also show that prevention of MV-induced oxidative stress via treatment with a mito-
chondrial-targeted antioxidant guards against CMV-induced decreases in protein synthesis
during 12 hours of CMV. A detailed discussion of these findings follows.
Fig 5. Ratio of p-mTOR to total mTOR protein in the diaphragm following 12 hours spontaneous breathing or mechanical ventilation.
Representative western blots are shown below the graph. Values are expressed as mean ± SE change from percent control. Symbols: * significantly different
(p<0.05) from all other groups.
doi:10.1371/journal.pone.0137693.g005
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Fig 6. Ratio of p-4E-BP1 to total 4E-BP1 protein in the diaphragm following 12 hours of spontaneous breathing or mechanical ventilation.
Representative western blots are shown below the graph. The ratio was determined via analysis of the sum total of all bands in both the phosphorylated and
total blots. Values are expressed as mean ± SE change from percent control. Symbols: * significantly different (p<0.05) from all groups.
doi:10.1371/journal.pone.0137693.g006
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PSV protects against the decreases in diaphragm protein synthesis that
occurs during prolonged CMV
The current report is only the second investigation to compare the differences in diaphragm
protein synthesis during both CMV and PSV. Futier et al. were the first investigators to report
that PSV can preserve diaphragm protein synthesis during prolonged MV [22]. However, two
experimental limitations exist in this report. First, in vivo diaphragm protein synthesis was not
measured during prolonged mechanical ventilation, but instead diaphragm protein synthesis
was assessed in vitro during a two-hour period following mechanical ventilation. Second, the
level of ventilator support provided to the animals during prolonged mechanical ventilation
was not determined and therefore the level of diaphragmatic contractile activity required to
maintain diaphragm protein synthesis remains unknown. The current experiments were
designed to eliminate these experimental drawbacks and provide new information missing
from this previous report.
It is established that full support MV (i.e., CMV) results in dramatic diaphragm muscle
atrophy in all fiber types in both humans and other animals [9, 44–48]. This CMV-induced
diaphragmatic atrophy occurs due to increased proteolysis and decreased diaphragmatic pro-
tein synthesis [49]. Further, previous work reveals that compared to CMV, PSV can delay the
rate of ventilator-induced diaphragm atrophy and contractile dysfunction [26]. The protective
effects of PSV against ventilator-induced diaphragm atrophy are likely due to the fact that dur-
ing PSV the diaphragm contracts and contributes to the work of breathing. In contrast, during
CMV the diaphragm remains inactive as the ventilator provides all of the work of breathing. In
the current experiments we assessed the work of breathing in both spontaneous breathing ani-
mals and animals supported by PSV. Our results indicate that compared to the work of sponta-
neous breathing, ventilating the animals using PSV reduced the work of breathing by ~67%.
Nonetheless, this level of PSV was successful in protecting against the decrease in diaphragm
protein synthesis that occurs during the first 12 hours of CMV.
To investigate the mechanism(s) responsible for the finding that PSV protects against
CMV-induced decreases in diaphragm protein synthesis we measured a key biomarker of oxi-
dative stress along with basic components of the AKT/mTOR signaling pathway. Compared to
CMV, PSV averted the CMV-induced oxidative stress in the diaphragm following 12 hours of
MV. This is important because oxidative stress can depress protein synthesis in several cell
types [27–29]. Further, because the AKT/mTOR signaling pathway plays an important role in
the regulation of cellular protein synthesis we measured diaphragmatic levels of key elements
involved in this pathway. Specifically, the AKT/mTOR pathway and its downstream targets,
ribosomal protein S6 and 4E-BP1, are immersed in the regulation of mRNA translation and
activation of the AKT/mTOR pathway can increase protein synthesis in skeletal muscle fibers
by promoting translation [50]. Compared to CMV, diaphragmatic levels of phosphorylated
(active) AKT, phosphorylated (active) mTOR, and phosphorylated 4E-BP1 were higher in the
PSV animals following 12 hours of MV. These findings are consistent with the observed higher
rates of diaphragmatic protein synthesis during PSV compared to CMV. Collectively, these
results indicate a general pattern of reduced anabolic signaling in the diaphragm following 12
hours of CMV that is averted using the level of PSV applied in these experiments. Interestingly,
while the majority of patients in the ICU receive PSV many still develop significant diaphragm
weakness. Since our results demonstrate that PSV maintains diaphragm protein synthesis, it is
likely that the diaphragm weakness occurring in patients receiving PSV is due to protein degra-
dation. This agrees with previous evidence that demonstrates that PSV can delay, but not pre-
vent, increased protein degradation in the diaphragm [26].
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Mitochondrial-targeted antioxidant administration provides protection
against MV-induced decreases in diaphragm protein synthesis
Oxidative damage to diaphragm lipids and proteins is a hallmark of VIDD (reviewed in [49]).
Importantly, previous work indicates that prevention of MV-induced oxidative stress via anti-
oxidants can defend against MV-induced diaphragm atrophy and contractile dysfunction [9,
24, 39, 41]. More specifically, recent studies reveal that increased mitochondria ROS produc-
tion during MV is a required upstream signal to promote diaphragm dysfunction in both ani-
mals and humans [21, 51]. Further, inhibition of MV-induced mitochondrial ROS emission
via administration of the mitochondrial-targeted antioxidant SS-31 can protect against both
diaphragm atrophy and contractile dysfunction in rats [19]. This previous study reveals that
SS-31 protects the diaphragm against increased proteolysis by inhibiting the activation of sev-
eral proteolytic systems (i.e. calpain, caspase-3 and the ubiquitin-proteasome system) [19].
Moreover, it is feasible that prevention of oxidative stress in the diaphragm can preserve the
rate of in vivo protein synthesis in the diaphragm during CMV. This prediction is based on evi-
dence indicating that increased oxidative stress is sufficient to depress the rates of protein syn-
thesis [27–29]. The current results reveal that treatment of animals with SS-31 successfully
prevented MV-induced oxidative stress in the diaphragm and protected against the MV-
induced decrease in diaphragm protein synthesis during 12 hours of CMV.
To investigate potential mechanisms responsible for this finding, we determined the impact
of the mitochondrial-targeted antioxidant SS-31 on AKT/mTORC1 signaling in the diaphragm
during prolonged CMV. Treatment with the mitochondrial targeted antioxidant prevented the
MV-induced decline in the activity of AKT, mTOR, and 4E-BP1 in the diaphragm. These data
suggest that treatment of animals with a mitochondrial-targeted antioxidant is not only able to
prevent the activation of key proteolytic enzymes in the diaphragm, but is also sufficient to
maintain protein synthesis possibly by maintaining activation of the AKT/mTORC1 signaling
pathway in the diaphragm.
Conclusions
These experiments attempted to identify therapeutic interventions that are capable of support-
ing protein synthesis in the diaphragm during prolonged CMV. Importantly, our results reveal
that compared to CMV, partial support mechanical ventilation (i.e., PSV) can protect against
ventilator-induced decreases in the rate of diaphragm protein synthesis during the first 12
hours of ventilator support. Further, our data also demonstrate that treatment with a mito-
chondrial-targeted antioxidant guards against CMV-induced decreases in protein synthesis
during 12 hours of CMV. The mechanism(s) responsible for the PSV and mitochondrial anti-
oxidant-mediated protection against depressed diaphragm protein synthesis are not completely
clear. Nonetheless, both experimental interventions (i.e., PSV and mitochondrial-targeted anti-
oxidant) prevent MV-induced oxidative stress in the diaphragm and results in higher activity
of Akt, mTOR, and 4E-BP1 in the diaphragm during 12 hours of prolonged MV. Additional
work is required to determine if these mechanisms are solely responsible for the maintenance
of protein synthesis in the diaphragm, and also to determine the effects of combining both
interventions. Further, future studies are needed to determine what specific proteins, such as
contractile proteins, are preserved through maintaining protein synthesis. Regardless of mech-
anisms or proteins are involved our findings suggest that the use of PSV and/or mitochondrial-
targeted antioxidants has the potential to maintain diaphragmatic protein synthesis during
prolonged ventilator support. This is important because maintaining protein synthesis in the
diaphragm during prolonged MV can protect against ventilator-induced diaphragmatic atro-
phy and weakness.
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